SCHEMBL521541

SCHEMBL521541

Clc1ccccc1C(Cl)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.53
TDO2 P48775 3/20 0.53
IDO2 Q6ZQW0 2/20 0.53
ACP3 P15309 1/20 0.50
TSHR P16473 5/20 0.48
HIF1A Q16665 2/20 0.48
LMNA P02545 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP2C9 P11712 1/20 0.48
KDM4E B2RXH2 1/20 0.48
NR1I2 O75469 1/20 0.48
ABCB11 O95342 1/20 0.48
NR3C1 P04150 1/20 0.48
PGR P06401 1/20 0.48
CYP3A4 P08684 1/20 0.48
ADRA2A P08913 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
MAPT P10636 1/20 0.48
CNR1 P21554 1/20 0.48
SLC6A2 P23975 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29901560 1.00 IDO1 (0.53) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11828154 0.93 TSHR (0.55) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11639869 0.87 TSHR (0.47) IDO1TDO2IDO2ACP3TSHR
SCHEMBL7873189 0.86 TSHR (0.66) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11617245 0.85 TSHR (0.50) IDO1TDO2IDO2ACP3TSHR
SCHEMBL7540828 0.85 IDO1 (0.56) IDO1TDO2IDO2ACP3TSHR
SCHEMBL28546831 0.83 TSHR (0.47) IDO1TDO2IDO2ACP3TSHR
SCHEMBL11644649 0.82 TSHR (0.43) IDO1TDO2IDO2ACP3TSHR
SCHEMBL365482 0.81 TSHR (0.44) ACP3TSHRHIF1ALMNACYP2C19
SCHEMBL10799696 0.79 ACP3 (0.48) ACP3TSHRLMNACYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12492225-B2 Melanocyte-regulating peptides IDP DISCOVERY PHARMA, S.L. (ES) 2025-12-09 US disclosed
US-12258423-B2 Stapled and stitched polypeptides and uses thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-03-25 US disclosed
CN-110105434-B Stapled and stitched polypeptides and uses thereof 哈佛大学的校长及成员们 2024-09-17 CN disclosed
US-20240294573-A1 CONSTRAINED PEPTIDES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-09-05 US disclosed
CN-113861131-B Preparation method of cetirizine impurity C 深圳菲斯生物科技有限公司 2024-04-19 CN disclosed
CN-113861131-B Preparation method of cetirizine impurity C 深圳菲斯生物科技有限公司 2024-04-19 CN disclosed
US-20240083943-A1 VEGF-REGULATING PEPTIDES IDP DISCOVERY PHARMA, S.L. (ES) 2024-03-14 US disclosed
WO-2023227771-A1 CYCLIC PEPTIDES WITH ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT (MDR) PATHOGENS Fundación Privada Instituto De Salud Global Barcelona (ES) 2023-11-30 WO disclosed
EP-4271480-A1 VEGF-REGULATING PEPTIDES IDP Discovery Pharma, S.L. (ES) 2023-11-08 EP disclosed
CN-116964074-A Peptides that modulate VEGF IDP研发制药有限公司 2023-10-27 CN disclosed
US-20100184645-A1 STITCHED POLYPEPTIDES PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-07-22 US disclosed
CN-101730708-A stitched polypeptides HARVARD COLLEGE 2010-06-09 CN disclosed
WO-2010011313-A2 LIGATION OF STAPLED POLYPEPTIDES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-01-28 WO disclosed
EP-2142562-A2 STITCHED POLYPEPTIDES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-01-13 EP disclosed
WO-2008127480-A2 PACKED BED MICROREACTORS CORNELL RESEARCH FOUNDATION, INC. (US) 2008-10-23 WO disclosed
WO-2008121767-A2 STITCHED POLYPEPTIDES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2008-10-09 WO disclosed
WO-2008028057-A2 SHIKIMIC ACID-DERIVED COMPOUNDS FOR INHIBITION AND DETECTION OF AURORA A-ASSOCIATED TUMORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2008-03-06 WO disclosed
US-5792775-A HIGH AFFINITY FOR DOPAMINE TRANSPORTER; INHIBIT DOPAMINE UPTAKE; DO NOT HAVE A COCAINE-LIKE BEHAVORIAL PROFILE; USED TO IMAGE BINDING SITES; DIAGNOSIS AND MONITORING OF NEURODEGENERATIVE DISEASES, E.G PARKINSON'S THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1998-08-11 US disclosed
US-5015710-A Catalytic addition polymerization HERCULES INCORPORATED (US) 1991-05-14 US disclosed
EP-0423521-A1 Process for producing polymer molded article HERCULES INCORPORATED (US) 1991-04-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12492225-B2 Melanocyte-regulating peptides MC1R, MITF, MCHR1 IDO1 102/4885TDO2 2329/4885IDO2 175/4885
US-20100184645-A1 STITCHED POLYPEPTIDES VIP, IAPP, NGLY1 IDO1 3069/4885TDO2 4643/4885IDO2 2961/4885
US-20240294573-A1 CONSTRAINED PEPTIDES IAPP, NGLY1, VIP IDO1 4036/4885TDO2 4754/4885IDO2 3867/4885
US-20240083943-A1 VEGF-REGULATING PEPTIDES VEGFA, FLT4, FLT1 IDO1 1488/4885TDO2 4773/4885IDO2 2343/4885
US-12258423-B2 Stapled and stitched polypeptides and uses thereof VIP, NGLY1, IAPP IDO1 2792/4885TDO2 3916/4885IDO2 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.